XML 17 R8.htm IDEA: XBRL DOCUMENT v3.22.1
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Cash flows from operating activities:    
Net loss $ (37,354) $ (67,730)
Adjustments to reconcile net loss to net cash provided by operating activities:    
(Gain) loss on sale or write down of assets, net (6,453) 21,283
Depreciation and amortization 75,673 80,812
Amortization of share and unit-based plans 4,869 4,030
Straight-line rent and amortization of above and below market leases 1,589 (4,959)
Provision for doubtful accounts 567 3,208
Income tax expense 1,799 2,238
Equity in loss (income) of unconsolidated joint ventures 29,097 (1,910)
Change in fair value of financing arrangement obligation 2,543 (863)
Changes in assets and liabilities, net of dispositions:    
Tenant and other receivables 28,098 52,684
Other assets 210 5,969
Due from affiliates (4,504) (3,619)
Accounts payable and accrued expenses 790 (7,328)
Other accrued liabilities (31,480) (31,596)
Net cash provided by operating activities 65,444 52,219
Cash flows from investing activities:    
Development, redevelopment, expansion and renovation of properties (13,377) (14,819)
Property improvements (7,022) (8,653)
Proceeds from repayment of notes receivable 0 1,300
Deferred leasing costs (372) (91)
Distributions from unconsolidated joint ventures 40,062 21,341
Contributions to unconsolidated joint ventures (19,422) (25,673)
Proceeds from collection of receivable in connection with sale of joint venture property 21,000 0
Proceeds from sale of assets 26,085 100,334
Net cash provided by investing activities 46,954 73,739
Cash flows from financing activities:    
Payments on mortgages, bank and other notes payable (53,237) (23,986)
Deferred financing costs 0 (3,472)
Payments on finance leases (571) (552)
Net (costs) proceeds from stock offerings (70) 597,007
Redemption of noncontrolling interests 0 (1)
Contribution from noncontrolling interests 0 125
Dividends and distributions (41,314) (26,670)
Net cash (used in) provided by financing activities (95,192) 542,451
Net increase in cash, cash equivalents and restricted cash 17,206 668,409
Cash, cash equivalents and restricted cash, beginning of period 166,971 482,659
Cash, cash equivalents and restricted cash, end of period 184,177 1,151,068
Supplemental cash flow information:    
Cash payments for interest, net of amounts capitalized 46,463 61,041
Non-cash investing and financing transactions:    
Accrued development costs included in accounts payable and accrued expenses and other accrued liabilities 18,881 25,248
Conversion of Operating Partnership Units to common stock 0 22,218
Accrued receivable of net proceeds from stock offering 0 41,137
Lease liabilities recorded in connection with right-of-use assets $ 24,929 $ 0